The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Therapy-related myeloid neoplasms: when genetics and environment collide
Open accessAbstract
Therapy-related myeloid neoplasms (t-MN) arise as a late effect of chemotherapy and/or radiation administered for a primary condition, typically a malignant disease, solid organ transplant or autoimmune disease. Survival is measured in months, not years, making t-MN one of the most aggressive and lethal cancers. In this Review, we discuss recent developments that reframe our understanding of the genetic and environmental aetiology of t-MN. Emerging data are illuminating who is at highest risk of developing t-MN, why t-MN are chemoresistant and how we may use this information to treat and ultimately prevent this lethal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Steensma, D. P., Bejar, R., Jaiswal, S., Lindsley, R. C., Sekeres, M. A., Hasserjian, R. P., & Ebert, B. L. (2015) · Blood · doi:10.1182/blood-2015-03-631747 · Cited by 1,971
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H., Sun, Z., Racevskis, J., Van Vlierberghe, P., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,946
Grimwade, D., Hills, R. K., Moorman, A. V., Walker, H., Chatters, S., Goldstone, A. H., Wheatley, K., Harrison, C. J., Burnett, A. K., & on behalf of the National Cancer Research Institute Adult Leukaemia Working Group (2010) · Blood · doi:10.1182/blood-2009-11-254441 · Cited by 1,938
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
Falini, B., Mecucci, C., Tiacci, E., Alcalay, M., Rosati, R., Pasqualucci, L., La Starza, R., Diverio, D., Colombo, E., Santucci, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041974 · Cited by 1,892
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Pritchard, C. C., Mateo, J., Walsh, M. F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603144 · Cited by 1,680
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
Shlush, L. I., Zandi, S., Mitchell, A., Chen, W. C., Brandwein, J. M., Gupta, V., Kennedy, J. A., Schimmer, A. D., Schuh, A. C., Yee, K. W., et al. (2014) · Nature · doi:10.1038/nature13038 · Cited by 1,443
Age and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339
Self-citationSomatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Ernst, T., Chase, A. J., Score, J., Hidalgo-Curtis, C. E., Bryant, C., Jones, A. V., Waghorn, K., Zoi, K., Ross, F. M., Reiter, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.621 · Cited by 1,139
Dnmt3a is essential for hematopoietic stem cell differentiation
Challen, G. A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J. S., Bock, C., Vasanthakumar, A., Gu, H., Xi, Y., et al. (2012) · Nature Genetics · doi:10.1038/ng.1009 · Cited by 1,122
Self-citationBone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Raaijmakers, M. H. G. P., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J. A., Ebert, B. L., Al-Shahrour, F., Hasserjian, R. P., Scadden, E. O., et al. (2010) · Nature · doi:10.1038/nature08851 · Cited by 1,115
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
Lindsley, R. C., Mar, B. G., Mazzola, E., Grauman, P. V., Shareef, S., Allen, S. L., Pigneux, A., Wetzler, M., Stuart, R. K., Erba, H. P., et al. (2015) · Blood · doi:10.1182/blood-2014-11-610543 · Cited by 991
Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., Löffler, H., Sauerland, C. M., Serve, H., Büchner, T., et al. (2002) · Blood · doi:10.1182/blood.v100.1.59 · Cited by 973
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Ebert, B. L., Pretz, J., Bosco, J., Chang, C. Y., Tamayo, P., Galili, N., Raza, A., Root, D. E., Attar, E., Ellis, S. R., et al. (2008) · Nature · doi:10.1038/nature06494 · Cited by 928
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Wong, T. N., Ramsingh, G., Young, A. L., Miller, C. A., Touma, W., Welch, J. S., Lamprecht, T. L., Shen, D., Hundal, J., Fulton, R. S., et al. (2015) · Nature · doi:10.1038/nature13968 · Cited by 892
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
Krönke, J., Fink, E. C., Hollenbach, P. W., MacBeth, K. J., Hurst, S. N., Udeshi, N. D., Chamberlain, P. P., Mani, D. R., Man, H. W., Gandhi, A. K., et al. (2015) · Nature · doi:10.1038/nature14610 · Cited by 863
Paschka, P., Schlenk, R. F., Gaidzik, V. I., Habdank, M., Krönke, J., Bullinger, L., Späth, D., Kayser, S., Zucknick, M., Götze, K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.3762 · Cited by 801
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Welch, J. S., Petti, A. A., Miller, C. A., Fronick, C. C., O’Laughlin, M., Fulton, R. S., Wilson, R. K., Baty, J. D., Duncavage, E. J., Tandon, B., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605949 · Cited by 796
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Wang, Y., Krivtsov, A. V., Sinha, A. U., North, T. E., Goessling, W., Feng, Z., Zon, L. I., & Armstrong, S. A. (2010) · Science · doi:10.1126/science.1186624 · Cited by 763
PVT1 dependence in cancer with MYC copy-number increase
Tseng, Y.-Y., Moriarity, B. S., Gong, W., Akiyama, R., Tiwari, A., Kawakami, H., Ronning, P., Reuland, B., Guenther, K., Beadnell, T. C., et al. (2014) · Nature · doi:10.1038/nature13311 · Cited by 722
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults
Young, A. L., Challen, G. A., Birmann, B. M., & Druley, T. E. (2016) · Nature Communications · doi:10.1038/ncomms12484 · Cited by 692
Smith, S. M., Le Beau, M. M., Huo, D., Karrison, T., Sobecks, R. M., Anastasi, J., Vardiman, J. W., Rowley, J. D., & Larson, R. A. (2003) · Blood · doi:10.1182/blood-2002-11-3343 · Cited by 682
Self-citationde Moor, J. S., Mariotto, A. B., Parry, C., Alfano, C. M., Padgett, L., Kent, E. E., Forsythe, L., Scoppa, S., Hachey, M., & Rowland, J. H. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1356 · Cited by 670
Substantial contribution of extrinsic risk factors to cancer development
Wu, S., Powers, S., Zhu, W., & Hannun, Y. A. (2016) · Nature · doi:10.1038/nature16166 · Cited by 666
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia
Yoshizato, T., Dumitriu, B., Hosokawa, K., Makishima, H., Yoshida, K., Townsley, D., Sato-Otsubo, A., Sato, Y., Liu, D., Suzuki, H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1414799 · Cited by 646
Detectable clonal mosaicism from birth to old age and its relationship to cancer
Laurie, C. C., Laurie, C. A., Rice, K., Doheny, K. F., Zelnick, L. R., McHugh, C. P., Ling, H., Hetrick, K. N., Pugh, E. W., Amos, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2271 · Cited by 594
Detectable clonal mosaicism and its relationship to aging and cancer
Jacobs, K. B., Yeager, M., Zhou, W., Wacholder, S., Wang, Z., Rodriguez-Santiago, B., Hutchinson, A., Deng, X., Liu, C., Horner, M.-J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2270 · Cited by 589
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
Starczynowski, D. T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2054 · Cited by 577
Mesenchymal Cell Contributions to the Stem Cell Niche
Kfoury, Y., & Scadden, D. T. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.02.019 · Cited by 546
Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis
McKerrell, T., Park, N., Moreno, T., Grove, C. S., Ponstingl, H., Stephens, J., Crawley, C., Craig, J., Scott, M. A., Hodkinson, C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.005 · Cited by 534
Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts
Kode, A., Manavalan, J. S., Mosialou, I., Bhagat, G., Rathinam, C. V., Luo, N., Khiabanian, H., Lee, A., Murty, V. V., Friedman, R., et al. (2014) · Nature · doi:10.1038/nature12883 · Cited by 532
Kim, G., Ison, G., McKee, A. E., Zhang, H., Tang, S., Gwise, T., Sridhara, R., Lee, E., Tzou, A., Philip, R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0887 · Cited by 528
Fleming, H. E., Janzen, V., Lo Celso, C., Guo, J., Leahy, K. M., Kronenberg, H. M., & Scadden, D. T. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.003 · Cited by 505
Kayser, S., Döhner, K., Krauter, J., Köhne, C.-H., Horst, H. A., Held, G., von Lilienfeld-Toal, M., Wilhelm, S., Kündgen, A., Götze, K., et al. (2011) · Blood · doi:10.1182/blood-2010-08-301713 · Cited by 487
Gibson, C. J., Lindsley, R. C., Tchekmedyian, V., Mar, B. G., Shi, J., Jaiswal, S., Bosworth, A., Francisco, L., He, J., Bansal, A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.6712 · Cited by 480
Gaidzik, V. I., Bullinger, L., Schlenk, R. F., Zimmermann, A. S., Röck, J., Paschka, P., Corbacioglu, A., Krauter, J., Schlegelberger, B., Ganser, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7926 · Cited by 456
Granfeldt Østgård, L. S., Medeiros, B. C., Sengeløv, H., Nørgaard, M., Andersen, M. K., Dufva, I. H., Friis, L. S., Kjeldsen, E., Marcher, C. W., Preiss, B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0890 · Cited by 451
Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer
Curtis, R. E., Boice, J. D., Stovall, M., Bernstein, L., Greenberg, R. S., Flannery, J. T., Schwartz, A. G., Weyer, P., Moloney, W. C., & Hoover, R. N. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262605 · Cited by 446
Hunter, C., Smith, R., Cahill, D. P., Stephens, P., Stevens, C., Teague, J., Greenman, C., Edkins, S., Bignell, G., Davies, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0127 · Cited by 434
Contiguous gene syndromes: A component of recognizable syndromes
Schmickel, R. D. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80377-8 · Cited by 407
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
Takahashi, K., Wang, F., Kantarjian, H., Doss, D., Khanna, K., Thompson, E., Zhao, L., Patel, K., Neelapu, S., Gumbs, C., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30626-x · Cited by 399
Bejar, R., Stevenson, K. E., Caughey, B., Lindsley, R. C., Mar, B. G., Stojanov, P., Getz, G., Steensma, D. P., Ritz, J., Soiffer, R., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.3381 · Cited by 396
Medyouf, H., Mossner, M., Jann, J.-C., Nolte, F., Raffel, S., Herrmann, C., Lier, A., Eisen, C., Nowak, V., Zens, B., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.014 · Cited by 388
Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer
Travis, L. B., Holowaty, E. J., Bergfeldt, K., Lynch, C. F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400504 · Cited by 359
Goodell, M. A., & Rando, T. A. (2015) · Science · doi:10.1126/science.aab3388 · Cited by 347
Tang, J.-L., Hou, H.-A., Chen, C.-Y., Liu, C.-Y., Chou, W.-C., Tseng, M.-H., Huang, C.-F., Lee, F.-Y., Liu, M.-C., Yao, M., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223784 · Cited by 344
Zambetti, N. A., Ping, Z., Chen, S., Kenswil, K. J. G., Mylona, M. A., Sanders, M. A., Hoogenboezem, R. M., Bindels, E. M. J., Adisty, M. N., Van Strien, P. M. H., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.021 · Cited by 342
p53-Mediated Hematopoietic Stem and Progenitor Cell Competition
Bondar, T., & Medzhitov, R. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.002 · Cited by 342
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
Schrader, K. A., Cheng, D. T., Joseph, V., Prasad, M., Walsh, M., Zehir, A., Ni, A., Thomas, T., Benayed, R., Ashraf, A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5208 · Cited by 339
Narumi, S., Amano, N., Ishii, T., Katsumata, N., Muroya, K., Adachi, M., Toyoshima, K., Tanaka, Y., Fukuzawa, R., Miyako, K., et al. (2016) · Nature Genetics · doi:10.1038/ng.3569 · Cited by 329
Chou, W.-C., Chou, S.-C., Liu, C.-Y., Chen, C.-Y., Hou, H.-A., Kuo, Y.-Y., Lee, M.-C., Ko, B.-S., Tang, J.-L., Yao, M., et al. (2011) · Blood · doi:10.1182/blood-2011-02-339747 · Cited by 322
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo
Woll, P. S., Kjällquist, U., Chowdhury, O., Doolittle, H., Wedge, D. C., Thongjuea, S., Erlandsson, R., Ngara, M., Anderson, K., Deng, Q., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.036 · Cited by 320
Gillis, N. K., Ball, M., Zhang, Q., Ma, Z., Zhao, Y., Yoder, S. J., Balasis, M. E., Mesa, T. E., Sallman, D. A., Lancet, J. E., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30627-1 · Cited by 317
MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
Chen, C., Liu, Y., Rappaport, A. R., Kitzing, T., Schultz, N., Zhao, Z., Shroff, A. S., Dickins, R. A., Vakoc, C. R., Bradner, J. E., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.016 · Cited by 311
Self-citationChristiansen, D. H., Andersen, M. K., & Pedersen-Bjergaard, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1405 · Cited by 308
Min, I. M., Pietramaggiori, G., Kim, F. S., Passegué, E., Stevenson, K. E., & Wagers, A. J. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.01.015 · Cited by 305
Implications of NRAS mutations in AML: a study of 2502 patients
Bacher, U., Haferlach, T., Schoch, C., Kern, W., & Schnittger, S. (2006) · Blood · doi:10.1182/blood-2005-08-3522 · Cited by 303
Regulation of hematopoietic stem cells by bone marrow stromal cells
Anthony, B. A., & Link, D. C. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.002 · Cited by 301
Fröhling, S., Schlenk, R. F., Kayser, S., Morhardt, M., Benner, A., Döhner, K., Döhner, H., & for the German-Austrian AML Study Group (2006) · Blood · doi:10.1182/blood-2006-04-014324 · Cited by 300
DNA Damage Induced by Alkylating Agents and Repair Pathways
Kondo, N., Takahashi, A., Ono, K., & Ohnishi, T. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/543531 · Cited by 292
DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia
Mistry, A. R., Felix, C. A., Whitmarsh, R. J., Mason, A., Reiter, A., Cassinat, B., Parry, A., Walz, C., Wiemels, J. L., Segal, M. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042715 · Cited by 281
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms
Liu, Y., Chen, C., Xu, Z., Scuoppo, C., Rillahan, C. D., Gao, J., Spitzer, B., Bosbach, B., Kastenhuber, E. R., Baslan, T., et al. (2016) · Nature · doi:10.1038/nature17157 · Cited by 279
Hulegårdh, E., Nilsson, C., Lazarevic, V., Garelius, H., Antunovic, P., Rangert Derolf, Å., Möllgård, L., Uggla, B., Wennström, L., Wahlin, A., et al. (2015) · American Journal of Hematology · doi:10.1002/ajh.23908 · Cited by 269
Narrowing and genomic annotation of the commonly deleted region of the 5q− syndrome
Boultwood, J., Fidler, C., Strickson, A. J., Watkins, F., Gama, S., Kearney, L., Tosi, S., Kasprzyk, A., Cheng, J.-F., Jaju, R. J., et al. (2002) · Blood · doi:10.1182/blood.v99.12.4638 · Cited by 264
Landscape of TET2 mutations in acute myeloid leukemia
Weissmann, S., Alpermann, T., Grossmann, V, Kowarsch, A., Nadarajah, N., Eder, C., Dicker, F., Fasan, A., Haferlach, C., Haferlach, T., et al. (2012) · Leukemia · doi:10.1038/leu.2011.326 · Cited by 261
Treatment-Associated Leukemia Following Testicular Cancer
Travis, L. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1165 · Cited by 254
A novel hierarchical prognostic model of AML solely based on molecular mutations
Grossmann, V., Schnittger, S., Kohlmann, A., Eder, C., Roller, A., Dicker, F., Schmid, C., Wendtner, C.-M., Staib, P., Serve, H., et al. (2012) · Blood · doi:10.1182/blood-2012-03-419622 · Cited by 252
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia
Maciejewski, J. P., Risitano, A., Sloand, E. M., Nunez, O., & Young, N. S. (2002) · Blood · doi:10.1182/blood.v99.9.3129 · Cited by 252
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
The Breast and Ovarian Cancer Susceptibility Collaboration, Ruark, E., Wellcome Trust Case Control Consortium, Snape, K., Humburg, P., Loveday, C., Bajrami, I., Brough, R., Rodrigues, D. N., Renwick, A., et al. (2013) · Nature · doi:10.1038/nature11725 · Cited by 248
Hou, H.-A., Kuo, Y.-Y., Liu, C.-Y., Chou, W.-C., Lee, M. C., Chen, C.-Y., Lin, L.-I., Tseng, M.-H., Huang, C.-F., Chiang, Y.-C., et al. (2012) · Blood · doi:10.1182/blood-2011-07-369934 · Cited by 241
Le Beau, M. M., Espinosa, R., Neuman, W. L., Stock, W., Roulston, D., Larson, R. A., Keinanen, M., & Westbrook, C. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5484 · Cited by 241
Self-citationMorton, L. M., Dores, G. M., Tucker, M. A., Kim, C. J., Onel, K., Gilbert, E. S., Fraumeni, J. F., & Curtis, R. E. (2013) · Blood · doi:10.1182/blood-2012-08-448068 · Cited by 233
Beau, M. M. L., Espinosa, R., Davis, E. M., Eisenbart, J. D., Larson, R. A., & Green, E. D. (1996) · PubMed · doi:10.1182/blood.v88.6.1930.bloodjournal8861930 · Cited by 232
Second Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy
Travis, L. B., Ng, A. K., Allan, J. M., Pui, C.-H., Kennedy, A. R., Xu, X. G., Purdy, J. A., Applegate, K., Yahalom, J., Constine, L. S., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr533 · Cited by 229
Chou, W.-C., Huang, H.-H., Hou, H.-A., Chen, C.-Y., Tang, J.-L., Yao, M., Tsay, W., Ko, B.-S., Wu, S.-J., Huang, S.-Y., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283291 · Cited by 227
Treatment-Related Myelodysplasia and Acute Leukemia in Non-Hodgkin’s Lymphoma Patients
Armitage, J. O., Carbone, P. P., Connors, J. M., Levine, A., Bennett, J. M., & Kroll, S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.113 · Cited by 224
Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential
Solimini, N. L., Xu, Q., Mermel, C. H., Liang, A. C., Schlabach, M. R., Luo, J., Burrows, A. E., Anselmo, A. N., Bredemeyer, A. L., Li, M. Z., et al. (2012) · Science · doi:10.1126/science.1219580 · Cited by 214
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
Ballinger, M. L., Goode, D. L., Ray-Coquard, I., James, P. A., Mitchell, G., Niedermayr, E., Puri, A., Schiffman, J. D., Dite, G. S., Cipponi, A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30147-4 · Cited by 213
Joslin, J. M., Fernald, A. A., Tennant, T. R., Davis, E. M., Kogan, S. C., Anastasi, J., Crispino, J. D., & Le Beau, M. M. (2007) · Blood · doi:10.1182/blood-2007-01-068809 · Cited by 210
Self-citationLiu, T. X., Becker, M. W., Jelinek, J., Wu, W.-S., Deng, M., Mikhalkevich, N., Hsu, K., Bloomfield, C. D., Stone, R. M., DeAngelo, D. J., et al. (2007) · Nature Medicine · doi:10.1038/nm1512 · Cited by 207
Cancer Survivorship Issues: Life After Treatment and Implications for an Aging Population
Rowland, J. H., & Bellizzi, K. M. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.8361 · Cited by 203
Less Is More: Unveiling the Functional Core of Hematopoietic Stem Cells through Knockout Mice
Rossi, L., Lin, K. K., Boles, N. C., Yang, L., King, K. Y., Jeong, M., Mayle, A., & Goodell, M. A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.08.006 · Cited by 194
Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications
Thol, F., Bollin, R., Gehlhaar, M., Walter, C., Dugas, M., Suchanek, K. J., Kirchner, A., Huang, L., Chaturvedi, A., Wichmann, M., et al. (2014) · Blood · doi:10.1182/blood-2013-07-518746 · Cited by 192
Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDS
Schneider, R. K., Ademà, V., Heckl, D., Järås, M., Mallo, M., Lord, A. M., Chu, L. P., McConkey, M. E., Kramann, R., Mullally, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.08.001 · Cited by 188
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
Muto, T., Sashida, G., Oshima, M., Wendt, G. R., Mochizuki-Kashio, M., Nagata, Y., Sanada, M., Miyagi, S., Saraya, A., Kamio, A., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20131144 · Cited by 178
Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L
Chen, D.-H., Below, J. E., Shimamura, A., Keel, S. B., Matsushita, M., Wolff, J., Sul, Y., Bonkowski, E., Castella, M., Taniguchi, T., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.04.009 · Cited by 178
Age-related somatic structural changes in the nuclear genome of human blood cells
Forsberg, L. A., Rasi, C., Razzaghian, H. R., Pakalapati, G., Waite, L., Thilbeault, K. S., Ronowicz, A., Wineinger, N. E., Tiwari, H. K., Boomsma, D., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.009 · Cited by 176
Melphalan May Be a More Potent Leukemogen than Cyclophosphamide
GREENE, M. H., HARRIS, E. L., GERSHENSON, D. M., MALKASIAN, G. D., MELTON, L. J., DEMBO, A. J., BENNETT, J. M., MOLONEY, W. C., & BOICE, J. D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-3-360 · Cited by 175
PHF6 mutations in adult acute myeloid leukemia
Van Vlierberghe, P., Patel, J., Abdel-Wahab, O., Lobry, C., Hedvat, C. V., Balbin, M., Nicolas, C., Payer, A. R., Fernandez, H. F., Tallman, M. S., et al. (2011) · Leukemia · doi:10.1038/leu.2010.247 · Cited by 171
Churpek, J. E., Marquez, R., Neistadt, B., Claussen, K., Lee, M. K., Churpek, M. M., Huo, D., Weiner, H., Bannerjee, M., Godley, L. A., et al. (2016) · Cancer · doi:10.1002/cncr.29615 · Cited by 169
Self-citationMyeloid malignancies and the microenvironment
Korn, C., & Méndez-Ferrer, S. (2017) · Blood · doi:10.1182/blood-2016-09-670224 · Cited by 169
The role of retinoids and retinoic acid receptors in normal hematopoiesis
Collins, S. (2002) · Leukemia · doi:10.1038/sj.leu.2402718 · Cited by 167
Bacher, U., Haferlach, T., Kern, W., Haferlach, C., & Schnittger, S. (2007) · Haematologica · doi:10.3324/haematol.10869 · Cited by 164
Offman, J., Opelz, G., Doehler, B., Cummins, D., Halil, O., Banner, N. R., Burke, M. M., Sullivan, D., Macpherson, P., & Karran, P. (2004) · Blood · doi:10.1182/blood-2003-11-3938 · Cited by 158
Steudel, C., Wermke, M., Schaich, M. A., Schäkel, U., Illmer, T., Ehninger, G., & Thiede, C. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10219 · Cited by 156
Nagamachi, A., Matsui, H., Asou, H., Ozaki, Y., Aki, D., Kanai, A., Takubo, K., Suda, T., Nakamura, T., Wolff, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.011 · Cited by 155
McNerney, M. E., Brown, C. D., Wang, X., Bartom, E. T., Karmakar, S., Bandlamudi, C., Yu, S., Ko, J., Sandall, B. P., Stricker, T. P., et al. (2012) · Blood · doi:10.1182/blood-2012-04-426965 · Cited by 154
Self-citationLeukemia in Atomic Bomb Survivors
Lange, R. D., Moloney, W. C., & YAMAWAKI, T. (1954) · Blood · doi:10.1182/blood.v9.6.574.574 · Cited by 147
Ok, C. Y., Patel, K. P., Garcia‐Manero, G., Routbort, M. J., Peng, J., Tang, G., Goswami, M., Young, K. H., Singh, R. R., Medeiros, L. J., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0139-z · Cited by 146
Wolff, A. C., Blackford, A. L., Visvanathan, K., Rugo, H. S., Moy, B., Goldstein, L. J., Stockerl-Goldstein, K. E., Neumayer, L. A., Langbaum, T. S., Theriault, R. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.6119 · Cited by 140
Bhatia, R., Krailo, M., Chen, Z., Burden, L., Askin, F. B., Dickman, P. S., Grier, H. E., Link, M. P., Meyers, P. A., Perlman, E. J., et al. (2006) · Blood · doi:10.1182/blood-2006-01-023101 · Cited by 139
Eichenauer, D. A., Thielen, I., Haverkamp, H., Franklin, J. G., Behringer, K., Halbsguth, T. V., Klimm, B. C., Diehl, V., Sasse, S., Rothe, A., et al. (2014) · Blood · doi:10.1182/blood-2013-07-512657 · Cited by 139
Somatic mosaicism: on the road to cancer
Fernández, L. C., Torres, M., & Real, F. X. (2015) · Nature reviews. Cancer · doi:10.1038/nrc.2015.1 · Cited by 139
Inactivating CUX1 mutations promote tumorigenesis
Wong, C. C., Martin, S., Rust, A. G., Rashid, M., Alifrangis, C., Alexandrov, L. B., Tiffen, J. C., Kober, C., Green, A. R., Massie, C. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2846 · Cited by 137
Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia
Shih, A. H., Chung, S. S., Dolezal, E. K., Zhang, S.-J., Abdel-Wahab, O. I., Park, C. Y., Nimer, S. D., Levine, R. L., & Klimek, V. M. (2013) · Haematologica · doi:10.3324/haematol.2012.076729 · Cited by 135
Christiansen, D. H., Andersen, M. K., & Pedersen-Bjergaard, J. (2004) · Blood · doi:10.1182/blood-2004-02-0754 · Cited by 135
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis
Jerez, A., Sugimoto, Y., Makishima, H., Verma, A. K., Jankowska, A. M., Przychodzen, B. P., Visconte, V., Tiu, R. V., O’Keefe, C. L., Mohamedali, A. M., et al. (2012) · Blood · doi:10.1182/blood-2011-12-397620 · Cited by 127
Fianchi, L., Pagano, L., Piciocchi, A., Candoni, A., Gaïdano, G., Breccia, M., Criscuolo, M., Specchia, G., Pogliani, E. M., Maurillo, L., et al. (2015) · American Journal of Hematology · doi:10.1002/ajh.23966 · Cited by 125
Ok, C. Y., Patel, K. P., Garcia‐Manero, G., Routbort, M. J., Fu, B., Tang, G., Goswami, M., Singh, R. R., Kanagal‐Shamanna, R., Pierce, S. A., et al. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.12.006 · Cited by 125
Characterization of Large Structural Genetic Mosaicism in Human Autosomes
Machiela, M. J., Zhou, W., Sampson, J. N., Dean, M. C., Jacobs, K. B., Black, A., Brinton, L. A., Chang, I., Chen, C., Chen, C., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.01.011 · Cited by 124
Mosaic Uniparental Disomies and Aneuploidies as Large Structural Variants of the Human Genome
Rodríguez‐Santiago, B., Malats, N., Rothman, N., Armengol, L., García‐Closas, M., Kogevinas, M., Villa, O., Hutchinson, A. A., Earl, J., Marenne, G., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.06.002 · Cited by 122
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemia
Babushok, D. V., Perdigones, N., Perin, J. C., Olson, T. S., Ye, W., Roth, J. J., Lind, C., Cattier, C., Li, Y., Hartung, H. D., et al. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.01.007 · Cited by 122
Christiansen, D. H., Andersen, M. K., Desta, F. Z., & Pedersen-Bjergaard, J. (2005) · Leukemia · doi:10.1038/sj.leu.2404009 · Cited by 121
Varney, M. E., Niederkorn, M., Konno, H., Matsumura, T., Gohda, J., Yoshida, N., Akiyama, T., Christie, S., Fang, J., Miller, D., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20141898 · Cited by 117
13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia
Parker, H., Rose-Zerilli, M. J. J., Parker, A. E., Chaplin, T., Wade, R. L., Gardiner, A. S., Griffiths, M., Collins, A. R., Young, B. D., Oscier, D. G., et al. (2010) · Leukemia · doi:10.1038/leu.2010.288 · Cited by 115
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q− syndrome
Kumar, M. S., Narla, A., Nonami, A., Mullally, A., Dimitrova, N., Ball, B. J., McAuley, J. R., Poveromo, L., Kutok, J. L., Galili, N., et al. (2011) · Blood · doi:10.1182/blood-2010-12-324715 · Cited by 113
Schulz, E., Valentin, A., Ulz, P., Beham‐Schmid, C., LIND, K., Rupp, V., Lackner, H., Wölfler, A., Zebisch, A., Olipitz, W., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100674 · Cited by 113
Topography, Clinical, and Genomic Correlates of 5q Myeloid Malignancies Revisited
Jerez, A., Gondek, L. P., Jankowska, A. M., Makishima, H., Przychodzen, B. P., Tiu, R. V., O’Keefe, C. L., Mohamedali, A. M., Batista, D., Sekeres, M. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1824 · Cited by 108
Therapy-Related Myelodysplastic Syndrome
Singh, Z. N., Huo, D., Anastasi, J., Smith, S. M., Karrison, T. G., Beau, M. M. L., Larson, R. A., & Vardiman, J. W. (2007) · American Journal of Clinical Pathology · doi:10.1309/nq3pmv4u8yv39jwj · Cited by 105
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma
Swisher, E. M., Harrell, M. I., Norquist, B. M., Walsh, T., Brady, M. F., Lee, M. J., Hershberg, R. M., Kalli, K. R., Lankes, H. A., Konnick, E. Q., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.6053 · Cited by 105
The Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS
Lane, S., Sykes, S. M., Al‐Shahrour, F., Shterental, S., Paktinat, M., Celso, C. L., Jesneck, J. L., Ebert, B. L., Williams, D. A., & Gilliland, D. G. (2010) · Blood · doi:10.1182/blood-2009-11-251728 · Cited by 102
Heuser, M., Yap, D., Leung, M., de Algara, T. R., Tafech, A., McKinney, S. E., Dixon, J., Thresher, R. R., Colledge, B., Carlton, M. B. L., et al. (2008) · Blood · doi:10.1182/blood-2008-06-162263 · Cited by 102
Lai, F., Godley, L. A., Joslin, J. M., Fernald, A. A., Liu, J., Espinosa, R., Zhao, N., Pamintuan, L., Till, B. G., Larson, R. A., et al. (2001) · Genomics · doi:10.1006/geno.2000.6414 · Cited by 98
Self-citationDöhner, K., Hehmann, U., Brown, J. M., Hetzel, C., Stewart, J., Lowther, G. W., Scholl, C., Fröhling, S., Cuneo, A., Tsui, L. ‐., et al. (2001) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-18156-6_3 · Cited by 94
Nardi, V., Winkfield, K. M., Ok, C. Y., Niemierko, A., Kluk, M., Attar, E. C., Garcia‐Manero, G., Wang, S. A., & Hasserjian, R. P. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.7340 · Cited by 94
Peng, J., Kitchen, S. M., West, R. A., Sigler, R. E., Eisenmann, K. M., & Alberts, A. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1467 · Cited by 93
Madan, V., Madan, B., Brykczynska, U., Zilbermann, F., Hogeveen, K. N., Döhner, K., Döhner, H., Weber, O., Blum, C., Rodewald, H.-R., et al. (2008) · Blood · doi:10.1182/blood-2008-02-142638 · Cited by 92
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
Järås, M., Miller, P. G., Chu, L. P., Puram, R. V., Fink, E. C., Schneider, R. K., Al-Shahrour, F., Peña, P., Breyfogle, L. J., Hartwell, K. A., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131033 · Cited by 92
Radivoyevitch, T., Sachs, R. K., Gale, R. P., Molenaar, R. J., Brenner, D. J., Hill, B. T., Kalaycio, M. E., Carraway, H. E., Mukherjee, S., Sekeres, M. A., et al. (2015) · Leukemia · doi:10.1038/leu.2015.258 · Cited by 92
Stoddart, A., Fernald, A. A., Wang, J., Davis, E. M., Karrison, T. G., Anastasi, J., & Beau, M. M. L. (2014) · Blood · doi:10.1182/blood-2013-07-517953 · Cited by 90
Ferrer, R. A., Wobus, M., List, C., Wehner, R., Schönefeldt, C., Brocard, B., Mohr, B., Rauner, M., Schmitz, M., Stiehler, M., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.083972 · Cited by 90
Maris, J. M., Wiersma, S. R., Mahgoub, N., Thompson, P., Geyer, R. J., Hurwitz, C. G., Lange, B. J., & Shannon, K. (1997) · PubMed · Cited by 89
Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia
Dumitriu, B., Feng, X., Townsley, D. M., Ueda, Y., Yoshizato, T., Calado, R. T., Yang, Y., Wakabayashi, Y., Kajigaya, S., Ogawa, S., et al. (2014) · Blood · doi:10.1182/blood-2014-10-607572 · Cited by 88
Recurrent CDC25C mutations drive malignant transformation in FPD/AML
Yoshimi, A., Toya, T., Kawazu, M., Ueno, T., Tsukamoto, A., Iizuka, H., Nakagawa, M. M., Nannya, Y., Arai, S., Harada, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms5770 · Cited by 88
Döhner, K., Brown, J. M., Hehmann, U., Hetzel, C., Stewart, J., Lowther, G. W., Scholl, C., Fröhling, S., Cuneo, A., Tsui, L., et al. (1998) · Blood · doi:10.1182/blood.v92.11.4031 · Cited by 87
Borthakur, G. M., Lin, E., Jain, N., Estey, E. E., Cortes, J. E., O'Brien, S. M., Faderl, S. H., Ravandi, F., Pierce, S. A., & Kantarjian, H. M. (2009) · Cancer · doi:10.1002/cncr.24367 · Cited by 86
Bello, C. M., Yu, D., Komrokji, R. S., Zhu, W., Wetzstein, G. A., List, A. F., & Lancet, J. E. (2010) · Cancer · doi:10.1002/cncr.25598 · Cited by 82
The p53 gene in pediatric therapy-related leukemia and myelodysplasia
Felix, C., Hosler, M. R., Provisor, D., Salhany, K., Sexsmith, E., Slater, D., Cheung, N., Winick, N., Strauss, E., Heyn, R. M., et al. (1996) · Blood · doi:10.1182/blood.v87.10.4376.bloodjournal87104376 · Cited by 80
Mll5 contributes to hematopoietic stem cell fitness and homeostasis
Zhang, Y., Wong, J. C. Y., Klinger, M., Tran, M. T., Shannon, K., & Killeen, N. P. (2008) · Blood · doi:10.1182/blood-2008-05-159905 · Cited by 77
van Doorn-Khosrovani, S. B. V. W., Spensberger, D., de Knegt, Y., Tang, M., Löwenberg, B., & Delwel, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208588 · Cited by 74
Minelli, A., Maserati, E., Nicolis, E., Zecca, M., Sainati, L., Longoni, D. V., Curto, F. L., Menna, G., Poli, F., Paoli, E. D., et al. (2009) · Leukemia · doi:10.1038/leu.2008.369 · Cited by 73
Is TP53 dysfunction required for BRCA1-associated carcinogenesis?
Schuyer, M., & Berns, E. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00117-3 · Cited by 73
Raaijmakers, M. H. G. P. (2012) · International Journal of Hematology · doi:10.1007/s12185-011-1001-x · Cited by 72
Haploinsufficiency of Apc leads to ineffective hematopoiesis
Wang, J., Fernald, A. A., Anastasi, J., Beau, M. M. L., & Qian, Z. (2010) · Blood · doi:10.1182/blood-2009-11-251835 · Cited by 72
Lehmann, S., O’Kelly, J., Raynaud, S., Funk, S. E., Sage, E. H., & Koeffler, H. P. (2007) · Leukemia · doi:10.1038/sj.leu.2404852 · Cited by 66
SETBP1 mutation analysis in 944 patients with MDS and AML
Thol, F. R., Suchanek, K. J., Koenecke, C., Stadler, M., Platzbecker, U., Thiede, C., Schroeder, T. A., Kobbe, G., Kade, S., Löffeld, P., et al. (2013) · Leukemia · doi:10.1038/leu.2013.145 · Cited by 63
Side, L. E., Curtiss, N. P., Teel, K., Kratz, C. P., Wang, P. W., Larson, R. A., Beau, M. M. L., & Shannon, K. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10320 · Cited by 62
Falconi, G., Fabiani, E., Fianchi, L., Criscuolo, M., Raffaelli, C. S., Bellesi, S., Hohaus, S., Voso, M. T., D’Alò, F., & Leone, G. G. M. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.10.005 · Cited by 58
Risk of myeloid neoplasms after solid organ transplantation
Morton, L. M., Gibson, T. M., Clarke, C. A., Lynch, C. F., Anderson, L. A., Pfeiffer, R. M., Landgren, O., Weisenburger, D. D., & Engels, E. A. (2014) · Leukemia · doi:10.1038/leu.2014.132 · Cited by 58
Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice
Chen, T. H.-P., Kambal, A., Krysiak, K., Walshauser, M. A., Raju, G., Tibbitts, J. F., & Walter, M. J. (2010) · Blood · doi:10.1182/blood-2010-06-293167 · Cited by 58
Acute DNA damage activates the tumour suppressor p53 to promote radiation-induced lymphoma
Lee, C., Castle, K. D., Moding, E. J., Blum, J. M., Williams, N. T., Luo, L., Ma, Y., Borst, L. B., Kim, Y., & Kirsch, D. G. (2015) · Nature Communications · doi:10.1038/ncomms9477 · Cited by 58
Felix, C. A., Megonigal, M. D., Chervinsky, D. S., Leonard, D. G. B., Tsuchida, N., Kakati, S., Block, A. M. W., Fisher, J. E., Grossi, M., Salhany, K., et al. (1998) · PubMed · doi:10.1182/blood.v91.12.4451 · Cited by 57
‘CHIP’ping away at clonal hematopoiesis
Link, D. C., & Walter, M. J. (2016) · Leukemia · doi:10.1038/leu.2016.130 · Cited by 57
NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features
Andersen, M. T., Andersen, M. K., Christiansen, D. H., & Pedersen-Bjergaard, J. (2008) · Leukemia · doi:10.1038/leu.2008.17 · Cited by 55
Recurrent genetic defects on chromosome 7q in myeloid neoplasms
Hosono, N., Makishima, H., Jerez, A., Yoshida, K., Przychodzen, B. P., McMahon, S., Shiraishi, Y., Chiba, K., Tanaka, H., Miyano, S., et al. (2014) · Leukemia · doi:10.1038/leu.2014.25 · Cited by 54
Kırkızlar, E., Zimmermann, B. G., Constantin, T. P., Swenerton, R., Hoang, B., Wayham, N. P., Babiarz, J., Demko, Z., Pelham, R. J., Kareht, S., et al. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.08.004 · Cited by 53
Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice
Vasanthakumar, A., Arnovitz, S., Marquez, R., Lepore, J. B., Rafidi, G., Asom, A. S., Weatherly, M., Davis, E. M., Neistadt, B., Duszynski, R. J., et al. (2015) · Blood · doi:10.1182/blood-2015-03-635599 · Cited by 53
Self-citationRojek, K., Nickels, E. M., Neistadt, B., Marquez, R., Wickrema, A., Artz, A. S., van Besien, K., Larson, R. A., Lee, M. K., Segal, J. P., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.08.002 · Cited by 53
Self-citationInfluence of Bone Marrow Microenvironment on Leukemic Stem Cells
Agarwal, P., & Bhatia, R. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.007 · Cited by 51
PPM1DMosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations
Pharoah, P. D. P., Song, H., Dicks, E., Intermaggio, M. P., Harrington, P. A., Baynes, C., Alsop, K., Chenevix‐Trench, G., Bogdanova, N. V., Cicek, M. S., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv347 · Cited by 50
Smith, M. R., Neuberg, D. S., Flinn, I. W., Grever, M. R., Lazarus, H. M., Rowe, J. M., Dewald, G. W., Bennett, J. M., Paietta, E. M., Byrd, J. C., et al. (2011) · Blood · doi:10.1182/blood-2011-03-342485 · Cited by 49
Therapy-induced malignant neoplasms in Nf1 mutant mice
Chao, R. C., Pyzel, U., Fridlyand, J., Kuo, Y., Teel, L., Haaga, J., Borowsky, A. D., Horvai, A., Kogan, S. C., Bonifas, J. M., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.011 · Cited by 48
Fanconi anemia gene variants in therapy-related myeloid neoplasms
Voso, M. T., Fabiani, E., Zang, Z., Fianchi, L., Falconi, G., Padella, A., Martini, M., Zhang, S. L., Santangelo, R., Larocca, L. M., et al. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.44 · Cited by 47
Pemmaraju, N., Shah, D., Kantarjian, H. M., Orlowski, R. Z., Nogueras‐González, G. M., Baladandayuthapani, V., Jain, N., Wagner, V., Garcia‐Manero, G., Shah, J. J., et al. (2014) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2014.07.001 · Cited by 47
Jacoby, M. A., Pizarro, R. E. D. J., Shao, J., Koboldt, D. C., Fulton, R. S., Zhou, G., Wilson, R. K., & Walter, M. J. (2013) · Leukemia · doi:10.1038/leu.2013.368 · Cited by 43
Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis
Zhao, Z., Chen, C.-C., Rillahan, C. D., Shen, R., Kitzing, T. M., McNerney, M. E., Díaz-Flores, E., Zuber, J. A., Shannon, K., Beau, M. M. L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3251 · Cited by 43
Self-citationFinke, J., Schmoor, C., Bertz, H., Marks, R., Wäsch, R., Zeiser, R., & Hackanson, B. W. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.338 · Cited by 42
The spectrum of somatic mutations in high‐risk acute myeloid leukaemia with ‐7/del(7q)
McNerney, M. E., Brown, C. D., Peterson, A. L., Banerjee, M., Larson, R. A., Anastasi, J., Beau, M. M. L., & White, K. P. (2014) · British Journal of Haematology · doi:10.1111/bjh.12964 · Cited by 38
Self-citationReduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes
Sundaravel, S., Duggan, R., Bhagat, T. D., Ebenezer, D. L., Liu, H., Yu, Y., Bartenstein, M., Unnikrishnan, M., Karmakar, S., Liu, T.-C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516394112 · Cited by 34
Preexisting TP53 mutation in therapy-related acute myeloid leukemia
Schulz, E., Kashofer, K., Heitzer, E., Mhatre, K. N., Speicher, M. R., Höefler, G., & Sill, H. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2191-0 · Cited by 34
Young, D. J., Stoddart, A., Nakitandwe, J., Chen, S.-C., Qian, Z. Y., Downing, J. R., & Beau, M. M. L. (2014) · Haematologica · doi:10.3324/haematol.2013.098657 · Cited by 30
Choi, G., Huang, B. Z., Pinarbasi, E. S., Braunstein, S. E., Horvai, A., Kogan, S. C., Bhatia, R., Faddegon, B., & Nakamura, J. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1728 · Cited by 30
Schick, U. M., McDavid, A., Crane, P. K., Weston, N., Ehrlich, K. J., Newton, K. M., Wallace, R. B., Bookman, E., Harrison, T. A., Aragaki, A. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059823 · Cited by 29
Christiansen, D. H., Desta, F., Andersen, M. K., & Pedersen-Bjergaard, J. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20426 · Cited by 26
Wong, J. C. Y., Weinfurtner, K. M., Alzamora, M. D. P., Kogan, S. C., Burgess, M. R., Zhang, Y., Nakitandwe, J., Ma, J., Cheng, J., Chen, S.-C., et al. (2015) · eLife · doi:10.7554/elife.07839 · Cited by 25
Stoddart, A., Wang, J., Fernald, A. A., Karrison, T. G., Anastasi, J., & Beau, M. M. L. (2013) · Blood · doi:10.1182/blood-2013-05-506568 · Cited by 23
Voso, M. T., Fabiani, E., Fianchi, L., Falconi, G., Criscuolo, M., Santangelo, R., Chiusolo, P., Betti, S., D’Alò, F., Hohaus, S., et al. (2012) · Leukemia · doi:10.1038/leu.2012.267 · Cited by 23
Momota, H., Nariata, Y., Miyakita, Y., Hosono, A., Makimoto, A., & Shibui, S. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22542 · Cited by 22
Gene deletion: a new target for cancer chemotherapy
Frei, E. (1993) · The Lancet · doi:10.1016/0140-6736(93)91764-d · Cited by 19
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms
Fabiani, E., Falconi, G., Fianchi, L., Criscuolo, M., Leone, G. G. M., & Voso, M. T. (2014) · Haematologica · doi:10.3324/haematol.2014.108159 · Cited by 16
Desta, F. Z., Christiansen, D. H., Andersen, M. K., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404072 · Cited by 12
Stoddart, A., Nakitandwe, J., Chen, S.-C., Downing, J. R., & Beau, M. M. L. (2015) · Blood · doi:10.1182/blood-2015-10-673228 · Cited by 11
Clonal haemopoiesis following cytotoxic therapy for lymphoma.
Cachia, P. G., Culligan, D. J., Clark, R. E., Whittaker, J. A., Jacobs, A., & Padua, R. A. (1993) · PubMed · Cited by 9
Cited by
Döhner, H., Wei, A. H., Appelbaum, F. R., Craddock, C., DiNardo, C. D., Dombret, H., Ebert, B. L., Fenaux, P., Godley, L. A., Hasserjian, R. P., et al. (2022) · Blood · doi:10.1182/blood.2022016867 · Cited by 3,279
Self-citationMolecular International Prognostic Scoring System for Myelodysplastic Syndromes
Bernard, E., Tuechler, H., Greenberg, P. L., Hasserjian, R. P., Arango Ossa, J. E., Nannya, Y., Devlin, S. M., Creignou, M., Pinel, P., Monnier, L., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2200008 · Cited by 867
Short, N. J., Rytting, M. E., & Cortes, J. E. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31041-9 · Cited by 781
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Bolton, K. L., Ptashkin, R. N., Gao, T., Braunstein, L., Devlin, S. M., Kelly, D., Patel, M., Berthon, A., Syed, A., Yabe, M., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00710-0 · Cited by 751
Advances in acute myeloid leukemia
Newell, L. F., & Cook, R. J. (2021) · BMJ · doi:10.1136/bmj.n2026 · Cited by 440
Metadata
- Authors
- McNerney, M. E., Godley, L. A., & Le Beau, M. M.
- Venue
- Nature Reviews Cancer
- Published
- 2017-08-24
- Volume
- 17
- Issue
- 9
- Pages
- 513-527
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2749642104
- Cited by
- 419
- References
- 195
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.